The management of ductal carcinoma in situ of the breast

Endocrine-Related Cancer

Volumn 8, Issue 1, 2001, Pages 33-45

  Skinner, K A ^a   Silverstein, M J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; CANCER FAMILY; CANCER GENETICS; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CARCINOMA IN SITU; COMEDO; CONFERENCE PAPER; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; PATIENT SELECTION; TREATMENT PLANNING; TUMOR VOLUME;

BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0034984130     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0080033     Document Type: Conference Paper

References (62)

1. DNA ploidy in intraductal breast carcinomas
2. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
3. Intraductal carcinoma of the breast
4. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ
5. Immunohistochemical demonstration of c-erbB-2 protein mammary ductal carcinoma in situ
6. Intraductal carcinoma: Long-term follow-up after treatment by biopsy alone
7. Cancer in the contralateral breast after radiotherapy for breast cancer
8. Consensus conference on the classification of ductal carcinoma in situ
9. Growth factors in breast cancer
10. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer
11. Incidence of and treatment for ductal carcinoma in situ of the breast
12. Three-dimensional imaging of mammary ductal carcinoma in situ: Clinical implications
13. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
14. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
15. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-17
16. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial
17. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Intraductal carcinoma (ductal carcinoma in situ)
18. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-I7: Intraductal carcinoma
19. Dose to the contralateral breast due to primary breast irradiation
20. Radiotherapy and tamoxifen following complete local excision in the management of ductal carcinoma in situ (DCIS): Preliminary results from the UK DCIS trial
21. Improved axillary staging of breast cancer with sentinel lymphadectomy
22. Intraductal carcinoma of the breast: Pathologic features associated with local recurrence in patients treated with breast-conserving therapy
23. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age
24. Cancer statistics 2000
25. Axillary dissection for ductal carcinoma in situ
26. Whole organ studies
27. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: First results of EORTC Randomized Phase III Trial 10853
28. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy
29. Sentinel node biopsy is indicated in breast cancer patients with high-risk DCIS or microinvasion
30. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe
31. Radiotherapy for early breast cancer: Was a comprehensive overview of trials needed?
32. Radiation therapy for in situ or localized breast cancer
33. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
34. Ductal carcinoma in situ: Percutaneous biopsy considerations
35. The rational development of biological therapies for breast cancer
36. Cell kinetics of histologic variants of in situ breast carcinoma
37. Scatter dose from tangential breast irradiation to the uninvolved breast
38. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
39. Pathologic analysis of the NSABP-B17 trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ
40. Intraductal carcinoma of the breast: Follow-up after biopsy only
41. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
42. Side effects of radiation therapy
43. Ipsilateral local recurrence in relation to therapy and morphologic characteristics in patients with ductal carcinoma in situ of the breast
44. The clinical significance of preinvasive breast carcinoma
45. Noninvasive breast carcinoma. Results of a national survey of the American College of Surgeons
46. The role of excision and surveillance alone in subclinical DCIS of the breast
47. Van Nuys Prognostic Index for DCIS
48. Prognostic factors and local recurrence in patients with ductal carcinoma in situ of the breast
49. Axillary dissection for intraductal breast carcinoma - Is it indicated?
50. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast
51. Prognostic classification of breast ductal carcinoma in situ
52. A prognostic index for ductal carcinoma in situ of the breast
53. Outcome after local recurrence in patients with ductal carcinoma in situ of the breast
54. The influence of margin width on local control in patients with ductal carcinoma in situ (DCIS) of the breast
55. Salvage treatment for local recurrence following breast conserving surgery and definitive irradiation for treatment of ductal carcinoma (intraductal carcinoma) of the breast
56. Fifteen year results of breast conserving surgery and definitive breast irradiation for treatment of ductal carcinoma in situ of the breast
57. The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy
58. Neu-protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage 2 breast cancer
59. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: The effect of age
60. Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast conserving therapy
61. Outcomes and factors impacting local recurrence of ductal carcinoma in situ
62. Tamoxifen after surgery/RT decreases local recurrence risk in DCIS patients